Heartflow Insider Rogers Campbell Files Form 4

TL;DR

**Heartflow insider Rogers Campbell just filed a Form 4, signaling a change in their holdings.**

AI Summary

Rogers Campbell, an insider at Heartflow, Inc., filed a Form 4 on March 23, 2026, indicating a change in beneficial ownership of securities. While the filing details don't specify a transaction, the filing itself signals that an insider's holdings have changed, which can be a key indicator for investors. This matters because insider activity, whether buying or selling, often provides clues about management's confidence in the company's future prospects, potentially influencing stock price.

Why It Matters

Insider filings like this can signal management's sentiment about the company's future, which can influence investor confidence and stock valuation.

Risk Assessment

Risk Level: low — This filing is purely informational and does not inherently pose a direct risk, but rather provides data for investor analysis.

Analyst Insight

A smart investor would monitor subsequent filings to see if this Form 4 indicates a significant buy or sell, and then research the reasons behind any such transaction to inform their investment decisions.

Key Players & Entities

• Rogers Campbell (person) — Reporting Person
• Heartflow, Inc. (company) — Issuer
• 0001585724 (person) — Rogers Campbell's CIK
• 0001464521 (company) — Heartflow, Inc.'s CIK

FAQ

Key Financial Figures

• $25.00 — n multiple trades at price ranging from $25.00 to $28.00. The price reported above ref
• $28.00 — trades at price ranging from $25.00 to $28.00. The price reported above reflects the

Filing Documents

• form4.html (4)
• form4.xml (4) — 14KB
• 0001464521-26-000048.txt ( ) — 16KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). X Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Rogers Campbell (Last) (First) (Middle) C/O HEARTFLOW, INC. 331 E. EVELYN AVENUE (Street) MOUNTAIN VIEW CALIFORNIA 94041 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Heartflow, Inc. [ HTFL ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Medical Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/19/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/19/2026 M (1) 19,402 A $ 2.22 95,436 D Common Stock 03/19/2026 M (2) 47,615 A $ 2.22 143,051 D Common Stock 03/19/2026 S (3) 64,533 D $ 25.6928 (4) 78,518 D Common Stock 22,615 I By Campbell Rogers 2019 Irrevocable Trust Common Stock 46,159 I By CR Asset Protection Trust of 2023 Common Stock 26,012 I By Spouse's Trust Common Stock 50,754 I By The Campbell Rogers Revocable Trust Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option $ 2.22 03/19/2026 M (1) 19,402 (5) 07/10/2033 Common Stock 19,402 $ 0 189,125 D Stock Option $ 2.22 03/19/2026 M (2) 47,615 (5) 07/10/2033 Common Stock 47,615 $ 0 141,510 D Explanation of Responses: 1. The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. 2. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. 3. Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. 4. This transaction was executed in multiple trades at price ranging from $25.00 to $28.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 5. The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date. /s/ Nga Van, by power of attorney 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissio

View Full Filing

View this 4 filing on SEC EDGAR